Katherine Morel

Dr Katherine Morel

Postdoctoral Researcher - SAiGENCI

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences

Dr. Katherine Morel is a Research Fellow in the South Australian Immunogenomics Cancer Institute (SAiGENCI) and Dame Roma Mitchell Cancer Research Laboratories (DRMCRL) at the University of Adelaide. in 2017, Dr. Morel was awarded her PhD from Flinders University in Adelaide, South Australia. Her doctoral research was carried out under the supervision of Prof. Pamela Sykes and focused on investigating the use of the anti-inflammatory compound parthenolide in the treatment and prevention of prostate cancer. Following the completion of her PhD studies, Dr. Morel continued her training as a Postdoctoral Research Fellow at the Dana-Farber Cancer Institute (DFCI), Harvard University in Boston, Massachusetts. At DFCI, Dr. Morel's research interests focused on genetic drivers of aggressive prostate cancer and identifying and utilising novel therapeutic approaches to target these genetic perturbations. This research utilised unique GEM and 3D organoid models of prostate cancer together with the latest techniques in genomics and proteomics. In 2022, Dr. Morel returned to Adelaide to continue her research into prostate cancer at the University of Adelaide.

  • Position: Postdoctoral Researcher - SAiGENCI
  • Phone: 83137336
  • Email: katherine.morel@adelaide.edu.au
  • Campus: NorthTerrace
  • Building: Adelaide Health and Medical Sciences, floor 8
  • Org Unit: South Australian Immunogenomics Cancer Institute

Connect With Me
External Profiles